Patents by Inventor Barbara Bennett

Barbara Bennett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Allogeneic human plasma and platelet derived products and uses thereof
    Patent number: 12576109
    Abstract: Provided herein are compositions comprising allogeneic human plasma and platelet derived product, and methods for making the compositions and using the compositions as a therapeutic for example, in orthopedic indications.
    Type: Grant
    Filed: April 30, 2025
    Date of Patent: March 17, 2026
    Assignee: Consano Bio, Inc.
    Inventors: Ehab Mosa Alshamleh, Barbara Bennett, Karen Fu, Andrew James Hall, Vishwesh Ashok Patil, Jennifer Louise Schmitke, Teresa Leah Wright, Jennifer Newman, William Kane Grier
  • ALLOGENEIC HUMAN PLASMA AND PLATELET DERIVED PRODUCTS AND USES THEREOF
    Publication number: 20250302873
    Abstract: Provided herein are compositions comprising allogeneic human plasma and platelet derived product, and methods for making the compositions and using the compositions as a therapeutic for example, in orthopedic indications.
    Type: Application
    Filed: April 30, 2025
    Publication date: October 2, 2025
    Inventors: Ehab Mosa Alshamleh, Barbara Bennett, Karen Fu, Andrew James Hall, Vishwesh Ashok Patil, Jennifer Louise Schmitke, Teresa Leah Wright, Jennifer Newman, William Kane Grier
  • COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN B (APOB) GENE EXPRESSION
    Publication number: 20220288237
    Abstract: The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of an apolipoprotein B (APOB) gene by targeting an APOB expression control region and methods of use thereof for treating an APOB associated disorder, e.g., hypercholesterolemia.
    Type: Application
    Filed: March 22, 2022
    Publication date: September 15, 2022
    Applicant: Omega Therapeutics, Inc.
    Inventors: Vishwesh Ashok Patil, Jeremiah D. Farelli, Rahul Karnik, Jesse Jerome Smith, Can Sarisozen, Adam Walter Scheidegger, Barbara Bennett
  • Method of making carbon foam at low pressure
    Patent number: 6797251
    Abstract: Methods of treating a carbon foam precursor to facilitate subsequent foaming of the material at low pressures, which may be on the order of about 0.5 to 1.5 atmospheres, are disclosed. In one embodiment, the carbon foam precursor is subjected to partial devolatilization under controlled conditions with subsequent foaming being effected at low pressure. The carbon foam precursor may be one of various forms of coal including raw coal, coal extract mesophase pitch, synthetic mesophase pitch or petroleum based pitch. The prefoaming treatment of the carbon foam precursor may remove a portion of the internal blowing agent and may alter the fluidity of the carbon foam precursor matrix. In another embodiment, the precursor after being converted into a powder is subjected to oxidation prior to foaming.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: September 28, 2004
    Assignee: West Virginia University
    Inventors: Barbara Bennett, Alfred Stiller
  • Process for blocking 5-HT and dopamine uptake with biologically active tropane derivatives
    Patent number: 6008227
    Abstract: Selective blockade of DA and 5-HT uptake sites with 3-aryltropane derivatives.
    Type: Grant
    Filed: May 18, 1993
    Date of Patent: December 28, 1999
    Assignee: Wake Forest University
    Inventors: Huw M. L. Davies, Steven R. Childers, Barbara Bennett